Pine Labs Limited
Pine Labs Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Sep 2026 | 22,582 | 179.6 | 3.83 | 0.07 | 197.58 |
| Sep 2026 | 23,123 | 173.3 | 3.52 | 0.07 | 181.96 |
| Sep 2026 | 23,425 | 158.7 | 3.39 | 0.07 | 173.02 |
| Sep 2026 | 23,425 | 158.7 | 3.39 | 0.07 | 173.02 |
| Sep 2026 | 23,422 | 161.7 | 3.39 | 0.07 | 173.02 |
| Sep 2026 | 23,428 | 155.9 | 3.39 | 0.07 | 173.02 |
| Oct 2026 | 21,555 | 151.0 | 3.28 | 0.07 | 167.59 |
| Oct 2026 | 21,273 | 146.9 | 3.19 | 0.07 | 163.07 |
Pine Labs Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 7,369,200,000.0 | 7,005,100,000.0 | 7,442,700,000.0 | 6,499,000,000.0 |
| Net Profit | 195,700,000.0 | 593,600,000.0 | 423,900,000.0 | 59,700,000.0 |
| EPS | 0.2 | 0.5 | 0.4 | 0.1 |
Pine Labs Limited Revenue & Profit: Last 4 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | 23,962,300,000.0 | 19,048,000,000.0 | 14,331,190,000.0 | 13,537,120,000.0 |
| Net Profit | 1,125,100,000.0 | -1,454,900,000.0 | -3,419,030,000.0 | -2,651,450,000.0 |
| EPS | 1.1 | -1.4 | -3.0 | -2.3 |
Pine Labs Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Total Assets | 132,969,600,000.0 | 107,157,300,000.0 | 96,485,640,000.0 | 93,632,060,000.0 |
| Total Liabilities | 74,015,500,000.0 | 72,095,800,000.0 | 61,066,330,000.0 | 56,242,240,000.0 |
| Total Equity | 58,954,100,000.0 | 35,061,500,000.0 | 35,419,310,000.0 | 37,389,820,000.0 |
Owes vs Owns
Pine Labs Limited owed ₹0.56 for every ₹1 it owned in Mar 2026, down from ₹0.60 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.56× | 0.67× | 0.63× | 0.60× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Pine Labs Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
How it's funded — Mar 2026
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 2,656.2 | 1,091.5 | 992.9 | 1,395.1 |
| Receivables | 1,042.1 | 844.9 | 652.0 | 589.4 |
| Inventory | 31.9 | 30.1 | 28.0 | 39.9 |
| Fixed assets (tangible) | 488.9 | 518.8 | 648.6 | 804.1 |
| Intangible assets | 1,528.6 | 1,467.7 | 1,493.7 | 1,569.9 |
| Long-term investments | 0.0 | 9.1 | 0.0 | 0.0 |
| Other assets | 7,549.2 | 6,753.6 | 5,833.4 | 4,964.9 |
| Liabilities & equity | ||||
| Short-term debt | 282.3 | 782.3 | 419.3 | 175.5 |
| Long-term debt | 0.6 | 47.2 | 113.6 | 154.0 |
| Payables | 383.1 | 541.7 | 389.8 | 368.1 |
| Other liabilities | 6,735.6 | 5,838.4 | 5,183.9 | 4,926.6 |
| Shareholders' equity | 5,895.4 | 3,506.2 | 3,541.9 | 3,739.0 |
| Net tangible assets | 4,366.8 | 2,038.5 | 2,048.2 | 2,169.1 |
Pine Labs Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Operating Activities | 3,953,900,000.0 | 497,200,000.0 | -2,290,050,000.0 | -1,523,600,000.0 |
| Investing Activities | -13,388,700,000.0 | -1,591,500,000.0 | 450,440,000.0 | -3,708,370,000.0 |
| Financing Activities | 19,721,700,000.0 | -2,010,900,000.0 | -2,195,070,000.0 | 23,410,000.0 |